Huandi Zhou

4.3k total citations · 1 hit paper
40 papers, 980 citations indexed

About

Huandi Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Huandi Zhou has authored 40 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Genetics. Recurrent topics in Huandi Zhou's work include Glioma Diagnosis and Treatment (12 papers), MicroRNA in disease regulation (9 papers) and Ferroptosis and cancer prognosis (9 papers). Huandi Zhou is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), MicroRNA in disease regulation (9 papers) and Ferroptosis and cancer prognosis (9 papers). Huandi Zhou collaborates with scholars based in China, United States and Japan. Huandi Zhou's co-authors include GG Illei, Ilias Alevizos, Peter S.T. Yuen, Xiaoying Xue, Ge Zhang, Guohui Wang, Yang Yu, Lei Tian, Zhifen Yang and Lin Mu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Scientific Reports.

In The Last Decade

Huandi Zhou

38 papers receiving 964 citations

Hit Papers

Exosomes from human saliva as a source of microRNA biomar... 2009 2026 2014 2020 2009 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Exosomes from human saliva as a source of microRNA biomarkers
    2009 593 citations Peter S.T. Yuen, Huandi Zhou et al. Oral Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huandi Zhou China 13 750 512 112 93 90 40 980
Farah Fatima Brazil 11 960 1.3× 599 1.2× 130 1.2× 58 0.6× 74 0.8× 13 1.2k
Pingli Xie China 13 495 0.7× 280 0.5× 180 1.6× 37 0.4× 144 1.6× 27 844
Victor Ma China 9 889 1.2× 491 1.0× 101 0.9× 58 0.6× 90 1.0× 16 1.0k
Jeffrey Schafer United States 6 1.0k 1.4× 928 1.8× 109 1.0× 43 0.5× 51 0.6× 9 1.3k
Ikrame Lazar France 11 776 1.0× 474 0.9× 137 1.2× 49 0.5× 155 1.7× 15 1.0k
Melanie Winkle Netherlands 10 1.2k 1.6× 992 1.9× 90 0.8× 72 0.8× 69 0.8× 13 1.4k
Mumtaz V. Rojiani United States 14 537 0.7× 281 0.5× 121 1.1× 101 1.1× 169 1.9× 29 931
Rudy F. Duisters Netherlands 6 742 1.0× 483 0.9× 59 0.5× 55 0.6× 63 0.7× 7 1.1k
Rebeca Galisteo United States 14 359 0.5× 164 0.3× 185 1.7× 99 1.1× 254 2.8× 18 840
Raquel Díaz Spain 15 928 1.2× 735 1.4× 76 0.7× 97 1.0× 229 2.5× 24 1.2k

Countries citing papers authored by Huandi Zhou

Since Specialization
Citations

This map shows the geographic impact of Huandi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huandi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huandi Zhou more than expected).

Fields of papers citing papers by Huandi Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huandi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huandi Zhou. The network helps show where Huandi Zhou may publish in the future.

Co-authorship network of co-authors of Huandi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Huandi Zhou. A scholar is included among the top collaborators of Huandi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huandi Zhou. Huandi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Sijie, et al.. (2025). The Prognostic Significance of TMSB4X in Glioma Patients. International Journal of General Medicine. Volume 18. 2923–2940. 1 indexed citations
2.
Zhou, Huandi, Xiaohui Ge, Haonan Li, et al.. (2024). Identification of an Immune signature assisted prognosis, and immunotherapy prediction for IDH wildtype glioblastoma. Journal of Cancer. 15(19). 6452–6467. 1 indexed citations
3.
Zhou, Huandi, et al.. (2023). SYST-23 CDK1 AS AN INDEPENDENT PROGNOSTIC INDICATOR AND POTENTIAL THERAPEUTIC TARGET IN GLIOMA. Neuro-Oncology Advances. 5(Supplement_3). iii32–iii32. 1 indexed citations
4.
Zhou, Huandi, Lin Mu, Zhifen Yang, & Yonghong Shi. (2023). Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy. Frontiers in Immunology. 14. 1113212–1113212. 9 indexed citations
5.
Zhou, Huandi, et al.. (2023). IDH1R132H mutation increases radiotherapy efficacy and a 4-gene radiotherapy-related signature of WHO grade 4 gliomas. Scientific Reports. 13(1). 19659–19659. 6 indexed citations
6.
Mu, Lin, et al.. (2022). Blocking REDD1/TXNIP Complex Ameliorates HG-Induced Renal Tubular Epithelial Cell Apoptosis and EMT through Repressing Oxidative Stress. International Journal of Endocrinology. 2022. 1–15. 9 indexed citations
7.
Zhou, Huandi, Zhifen Yang, Lin Mu, & Yonghong Shi. (2022). Integrated Analysis of Multiple Microarray Studies to Identify Core Gene‐Expression Signatures Involved in Tubulointerstitial Injury in Diabetic Nephropathy. BioMed Research International. 2022(1). 9554658–9554658. 6 indexed citations
8.
Yang, Haiyan, Huandi Zhou, Guohui Wang, et al.. (2022). MELK is a prognostic biomarker and correlated with immune infiltration in glioma. Frontiers in Neurology. 13. 977180–977180. 10 indexed citations
9.
Zhang, Yufeng, Haiyan Yang, Liwen Wang, et al.. (2022). TOP2A correlates with poor prognosis and affects radioresistance of medulloblastoma. Frontiers in Oncology. 12. 918959–918959. 15 indexed citations
10.
Zhang, Dongdong, Wenyan Wang, Huandi Zhou, et al.. (2022). ANXA1: An Important Independent Prognostic Factor and Molecular Target in Glioma. Frontiers in Genetics. 13. 851505–851505. 6 indexed citations
11.
Zhou, Huandi, Guohui Wang, Yang Yu, et al.. (2022). NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 12. 831506–831506. 5 indexed citations
12.
Zhou, Huandi, et al.. (2021). Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma. BioMed Research International. 2021(1). 7479326–7479326. 16 indexed citations
13.
Xue, Xiaoying, et al.. (2021). DNMT family induces down-regulation of NDRG1 via DNA methylation and clinicopathological significance in gastric cancer. PeerJ. 9. e12146–e12146. 8 indexed citations
14.
Tian, Lei, et al.. (2021). The relationship between PLOD1 expression level and glioma prognosis investigated using public databases. PeerJ. 9. e11422–e11422. 7 indexed citations
15.
Xue, Xiaoying, Yang Yu, Huandi Zhou, & Ge Zhang. (2019). Targeting the canonical Wnt/β-catenin pathway in cancer radioresistance: Updates on the molecular mechanisms. Journal of Cancer Research and Therapeutics. 15(2). 272–272. 25 indexed citations
16.
Xue, Xiaoying, et al.. (2017). A molecular view of the radioresistance of gliomas. Oncotarget. 8(59). 100931–100941. 71 indexed citations
17.
Zhou, Huandi, et al.. (2016). microRNAs regulation and its role as biomarkers in diseases ⁎. Oncology and Translational Medicine. 2(1). 39–46. 1 indexed citations
18.
Zhang, Yanli, Jun Tang, Ning Yang, et al.. (2016). FAT10 Is Critical in Influenza A Virus Replication by Inhibiting Type I IFN. The Journal of Immunology. 197(3). 824–833. 19 indexed citations
19.
Zhang, Ge, Huandi Zhou, & Xiaoying Xue. (2016). Complex roles of NRAGE on tumor. Tumor Biology. 37(9). 11535–11540. 14 indexed citations
20.
Yuen, Peter S.T., et al.. (2009). Exosomes from human saliva as a source of microRNA biomarkers. Oral Diseases. 16(1). 34–38. 593 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farah Fatima Breakdown of academic impact, for papers by Pingli Xie Breakdown of academic impact, for papers by Victor Ma Breakdown of academic impact, for papers by Jeffrey Schafer Breakdown of academic impact, for papers by Ikrame Lazar Breakdown of academic impact, for papers by Melanie Winkle Breakdown of academic impact, for papers by Mumtaz V. Rojiani Breakdown of academic impact, for papers by Rudy F. Duisters Breakdown of academic impact, for papers by Rebeca Galisteo Breakdown of academic impact, for papers by Raquel Díaz
Rankless by CCL
2026